Literature DB >> 16267670

Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment.

Roselie M H Diederen1, Ellen C La Heij, Nicolaas E P Deutz, Alfons G H Kessels, Hans M H van Eijk, Fred Hendrikse.   

Abstract

BACKGROUND: Nitric oxide (NO) plays a significant role in physiological and pathological processes in the retina. In the L-arginine-NO pathway, NO synthase (NOS) converts L-arginine to NO and L-citrulline. Increased NO production, mediated by inducible NOS has been implicated in the pathogenesis of various vitreoretinal diseases. In the present study it is hypothesized that in rhegmatogenous retinal detachment (RRD), the production of NO pathway metabolites might be upregulated.
METHODS: Using high-pressure liquid chromatography citrulline, arginine and nitrite were measured in vitreous fluid of 93 eyes with RRD, nine eyes with a traction retinal detachment due to proliferative diabetic retinopathy (PDR), and in 49 control samples of vitreous fluid from eyes without retinal detachment.
RESULTS: The mean vitreous concentrations of citrulline and arginine were significantly increased in eyes with RRD (9.6+/-4.3 and 97.3+/-29.2; respectively) or in eyes with a traction retinal detachment (25.8+/-10.3 and 130.7+/-23.7; respectively) as compared to control eyes (7.1+/-3.2 and 75.9+/-18.1; respectively). The mean level of nitrite was also higher in vitreous fluid of patients with RRD (2.24+/-1.4) or patients with a traction retinal detachment (2.21+/-0.72) than in the controls (2.01+/-0.72), although not significantly so.
CONCLUSIONS: We found increased levels of NO pathway metabolites in the vitreous fluid of eyes with retinal detachment, which may reflect a possible role of NO in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267670     DOI: 10.1007/s00417-005-0141-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1.  Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments.

Authors:  E C La Heij; F Hendrikse; A G Kessels
Journal:  Retina       Date:  2001       Impact factor: 4.256

Review 2.  The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.

Authors:  D W Choi; S M Rothman
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

3.  Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column.

Authors:  H M van Eijk; D R Rooyakkers; N E Deutz
Journal:  J Chromatogr       Date:  1993-10-22

4.  Aminoguanidine-treatment results in the inhibition of lens opacification and calpain-mediated proteolysis in Shumiya cataract rats (SCR).

Authors:  M Inomata; M Hayashi; S Shumiya; S Kawashima; Y Ito
Journal:  J Biochem       Date:  2000-11       Impact factor: 3.387

5.  Induction of citrulline-nitric oxide (NO) cycle enzymes and NO production in immunostimulated rat RPE-J cells.

Authors:  Takahisa Koga; Wen Yi Zhang; Tomomi Gotoh; Seiichi Oyadomari; Hidenobu Tanihara; Masataka Mori
Journal:  Exp Eye Res       Date:  2003-01       Impact factor: 3.467

6.  Levels of basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in subretinal fluid from patients with retinal detachment.

Authors:  E C La Heij; M P Van De Waarenburg; H G Blaauwgeers; A G Kessels; J De Vente; A T Liem; H Steinbusch; F Hendrikse
Journal:  Am J Ophthalmol       Date:  2001-10       Impact factor: 5.258

Review 7.  Nitric oxide in the eye: multifaceted roles and diverse outcomes.

Authors:  F Becquet; Y Courtois; O Goureau
Journal:  Surv Ophthalmol       Date:  1997 Jul-Aug       Impact factor: 6.048

Review 8.  Nitric oxide neurotoxicity.

Authors:  V L Dawson; T M Dawson
Journal:  J Chem Neuroanat       Date:  1996-06       Impact factor: 3.052

9.  Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production.

Authors:  R G Tilton; K Chang; J A Corbett; T P Misko; M G Currie; N S Bora; H J Kaplan; J R Williamson
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-07       Impact factor: 4.799

10.  Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.

Authors:  B Kenarova; L Voinov; C Apostolov; R Vladimirova; A Misheva
Journal:  Eur J Ophthalmol       Date:  1997 Jan-Mar       Impact factor: 1.922

View more
  8 in total

1.  Measurement of region-specific nitrate levels of the posterior chamber of the rat eye using low-flow push-pull perfusion.

Authors:  Jeanita S Pritchett; Jose S Pulido; Scott A Shippy
Journal:  Anal Chem       Date:  2008-06-13       Impact factor: 6.986

2.  Capillary electrophoretic assay for nitrate levels in the vitreous of proliferative diabetic retinopathy.

Authors:  Leyi Gao; Jose S Pulido; R Mark Hatfield; Robert F Dundervill; Colin A McCannel; Scott A Shippy
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-11-13       Impact factor: 3.205

3.  Is pseudoexfoliation syndrome associated with vitreoretinal interface abnormalities?

Authors:  Seda Karaca Adıyeke; Neslisah Kutlu; Kıvanç Özen; Mehmet Ali Doran; Kemal Demirbaş; Gamze Ture; Ekrem Talay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-18       Impact factor: 3.117

4.  TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.

Authors:  B Cameron Carr; Caitlyn E Emigh; Lea D Bennett; Andrew D Pansick; David G Birch; Chan Nguyen
Journal:  Retina       Date:  2017-01       Impact factor: 4.256

5.  Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment.

Authors:  Ozgur Yalcinbayir; Rifat Levent Buyukuysal; Oner Gelisken; Cagatay Buyukuysal; Basak Can
Journal:  Mol Vis       Date:  2014-09-21       Impact factor: 2.367

6.  Short-time prone posturing is well-tolerated and reduces the rate of unintentional retinal displacement in elderly patients operated on for retinal detachment.

Authors:  Roberto dell'Omo; Francesco Semeraro; Germano Guerra; Marco Verolino; Mariapia Cinelli; Stefania Montagnani; Ciro Costagliola
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

Review 7.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

Review 8.  Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases.

Authors:  Fátima Milhano Santos; Joana Mesquita; João Paulo Castro-de-Sousa; Sergio Ciordia; Alberto Paradela; Cândida Teixeira Tomaz
Journal:  Antioxidants (Basel)       Date:  2022-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.